ASO and siRNA Therapeutics for CNS and Liver Disorders

Vanderbilt University

Nissan Chemical is seeking ASO and siRNA therapeutics for CNS and liver diseases.

Reference No.

RFP-2025-3128

Description

Nissan Chemical Corporation, a forerunner in chemical innovations, is seeking novel ASO and siRNA therapeutics for CNS and liver diseases.

This Request for Proposal (RFP) is issued by Kansas City Board of Public Utilities ('Purchaser') for a Workforce Management Software solution. The scope includes absence management, scheduling, time & labor, and related automations to improve productivity, redual review, and support effective allocation of resources. Modules should support configurable rules, role-based permissions, and audit-ready reporting. This Request for Proposal (RFP) is issued by Kansas City Board of Public Utilities ('Purchaser') for a Workforce Management Software solution. The scope includes absence management, scheduling, time & labor, and related automations to improve productivity, reduce manual review, and support effective allocation of resources. Modules should support configurable rules, role-based permissions, and

Unlock full RFP details

Key Requirements

RFP Submission Requirements for Vanderbilt CNS/Liver Therapeutics

Contact Information

Get contact info

What you’ll get when you unlock

All the details after a short form. No spam